Narrow Results Clear All
- Audiovisual 3
- Book/Report 1
- Legislation/Regulation 6
- Tools/Toolkit 8
- Web Resource 55
- Award 11
- Grant 3
- Meeting/Conference 1
- Press Release/Announcement
- Communication Improvement 12
- Culture of Safety 4
- Education and Training 23
- Error Reporting and Analysis 18
- Human Factors Engineering 23
- Legal and Policy Approaches 23
- Quality Improvement Strategies 28
- Specialization of Care 1
- Teamwork 1
- Technologic Approaches 7
- Device-related Complications 18
- Diagnostic Errors 4
- Discontinuities, Gaps, and Hand-Off Problems 1
- Drug shortages 3
- Identification Errors 2
- Medical Complications 9
- Medication Errors/Preventable Adverse Drug Events 46
- MRI safety 4
- Nonsurgical Procedural Complications 3
- Surgical Complications 4
- Transfusion Complications 1
- Internal Medicine 22
- Nursing 2
- Pharmacy 38
- Health Care Executives and Administrators 59
Health Care Providers
- Nurses 12
- Pharmacists 16
- Physicians 19
Non-Health Care Professionals
- Media 4
- Patients 24
- Africa 1
- Asia 1
- Australia and New Zealand 1
- Central and South America 1
- Europe 4
- Canada 2
- United States of America 109
Search results for "Health Care Providers"
- Press Release/Announcement
- Health Care Providers
Washington DC: National Academy of Medicine and the Aspen Institute.
Despite increased awareness regarding the public health impacts of opioid misuse and overdose in the United States, the complexity of the problem has hindered the effectiveness of improvement efforts. This website highlights the work of a multiorganizational collaborative to explore systemic solutions to address the opioid crisis. An Annual Perspective discussed the impact of the opioid epidemic on patient safety.
Horsham, PA: Institute for Safe Medication Practices; July 26, 2018.
Institute for Safe Medication Practices.
Horsham, PA: Institute for Safe Medication Practices; 2018.
Results from this survey will inform the revision of a high-alert medication list used to raise awareness about drugs that have heightened potential to cause patient harm if used incorrectly.
Safe handling of concentrated electrolyte products from outsourcing facilities during critical drug shortages.
National Alert Network. Horsham, PA: Institute for Safe Medication Practices; Bethesda, MD: American Society of Health-System Pharmacists. May 24, 2018.
Drug shortages can necessitate hospitals to find alternative sources for important medications. This alert raises awareness of risks associated with potassium chloride use due to variations in labeling, packaging, or concentration of outsourced medications. Recommendations include use of barcode scanning and communicating with staff regarding drug shortages.
Bethesda, MD: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. May 21, 2018. PA-18-790; PA-18-791.
The Institute for Safe Medication Practices.
Structured interaction with a wide variety of experts and environments enables medication safety improvement. This 2-week educational program provides international clinicians with the opportunity to work with leaders based in the United States to engage in incident analysis, project design, and strategic planning to enhance medication safety efforts in their home countries.
Food and Drug Administration, Institute for Safe Medication Practices.
This fellowship program provides clinicians with learning opportunities at the Institute for Safe Medication Practices and the US Food and Drug Administration. The appointment consists of a pair of successive 6-month positions designed to provide experience in both system improvement and regulatory approaches to enhance medication safety. The process for submitting applications is now closed.
Joint Commission. March 12, 2018.
The Eisenberg Award honors individuals and organizations who have made unique and sustained contributions to the work of patient safety and quality improvement. The 2017 honorees are Dr. Thomas Gallagher; Children's Hospitals' Solutions for Patient Safety; and LifePoint Health's National Quality Program, Brentwood, Tennessee. The awards were presented at the National Quality Forum annual conference on March 12, 2018 in Washington, DC.
Institute for Safe Medication Practices.
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 11, 2018.
National Alert Network. Horsham, PA: Institute for Safe Medication Practices; Bethesda, MD: American Society of Health-System Pharmacists. October 12, 2017.
Care devices that enable patients to administer medicines at home can have unintended consequences. This alert raises awareness of hazards related to insulin pen misuse and offers recommendations to reduce risks, such as training patients to properly use pen needles and engaging community pharmacists in verifying that patients understand appropriate administration techniques.
Horsham, PA: Institute for Safe Medication Practices; 2017.
High-alert medications have the potential to cause substantial patient harm if administration mistakes occur. This assessment tool will enable organizations across a range of care environments to determine opportunities for improvement in 11 high-alert medication categories. In addition, the tool provides an opportunity for organizations to submit their data anonymously to a national data collection effort led by the Institute for Safe Medication Practices to define the current state of high-alert medication practices in health care. The data submission process is now closed.
Horsham, PA: Institute for Safe Medication Practices; August 24, 2017.
Horsham, PA: Institute for Safe Medication Practices; January 11, 2017.
Request for comments on the proposed measures and 2020 targets for the National Action Plan for Adverse Drug Event Prevention: inpatient and outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics.
Federal Register. Washington, DC: Office of Disease Prevention and Health Promotion, US Department of Health and Human Services. October 20, 2016;81:72594-72595.
National attention has focused on efforts to address adverse drug events. This call for comments seeks insights regarding revisions to a 2014 action plan that highlighted how to reduce adverse drug events associated with anticoagulants, diabetes agents, and opioids. These proposed updates involve measures to apply in both the inpatient and outpatient environments to track adverse drug events. The opportunity to submit written comments is now closed.
Joint Commission. April 7, 2016.
The Eisenberg Award honors individuals and organizations who have made vital accomplishments in improving patient and quality. The 2015 honorees are Pascale Carayon, PhD; Premier, Inc.; and Mayo Clinic Hospital-Rochester. The awards were presented at the National Quality Forum's annual conference on April 7, 2016, in Washington, DC.
FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 4, 2016.
This announcement alerts prescribers to differences in two oral formulations of the same medication that can lead to dosing errors. The FDA suggests that clinicians specify dosage form, strength, and frequency on prescriptions for this drug to reduce the risk of patient harm and recommend that pharmacists follow up with prescribers if such information is missing.
FDA Safety Communication. Silver Spring, MD: US Food and Drug Administration; September 17, 2015.
Use of incompletely cleaned medical devices has been linked to health care–associated infections. Drawing from reports submitted to the FDA regarding infections related to reprocessed flexible bronchoscopes, this announcement offers recommendations to enhance the reliability of scope sterilization methods.
Society to Improve Diagnosis in Medicine.
Diagnostic error is garnering increased attention as a key area of focus in patient safety improvement. This fellowship program for physicians who have completed their residency will provide the opportunity to build expertise in enhancing diagnostic safety. The application process for the 2017–2018 year is closed.